The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kopczynski Casey C. since 2018.
This trader's CIK number is 1590001.
At the time of last reporting, Kopczynski Casey C. was the Chief Scientific Officer of Aerie Pharmaceuticals Inc. (stock ticker symbol AERI).
Also see all insider trading activities at Aerie Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | AERI | 0 | $0 | 0 | $0 | 60,651 | $11,887 |
| 2020 | AERI | 0 | $0 | 30,000 | $390,181 | 0 | $0 |
| 2019 | AERI | 0 | $0 | 22,000 | $899,107 | 117,000 | $47,385 |
| 2018 | AERI | 0 | $0 | 79,708 | $4,634,981 | 6,251 | $16,284 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-15 | AERI | Option Ex | 60,651 | .20 | 11,887 |
| 2020-11-10 | AERI | Sale | 7,305 | 13.00 | 94,965 |
| 2020-11-11 | AERI | Sale | 22,695 | 13.01 | 295,216 |
| 2019-12-03 | AERI | Option Ex | 117,000 | .41 | 47,385 |
| 2019-02-01 | AERI | Sale | 11,000 | 46.53 | 511,797 |
| 2019-01-02 | AERI | Sale | 11,000 | 35.21 | 387,310 |
| 2018-12-03 | AERI | Sale | 11,000 | 40.17 | 441,837 |
| 2018-11-01 | AERI | Sale | 11,000 | 53.61 | 589,699 |
| 2018-02-09 | AERI | Option Ex | 3,251 | .40 | 1,284 |
| 2018-10-01 | AERI | Sale | 11,000 | 60.88 | 669,702 |
| 2018-09-04 | AERI | Sale | 11,000 | 60.50 | 665,511 |
| 2018-08-01 | AERI | Sale | 11,000 | 68.34 | 751,783 |
| 2018-07-02 | AERI | Sale | 11,000 | 66.62 | 732,809 |
| 2018-06-06 | AERI | Sale | 11,000 | 58.89 | 647,834 |
| 2018-05-29 | AERI | Sale | 2,708 | 50.15 | 135,806 |
| 2018-05-24 | AERI | Option Ex | 3,000 | 5.00 | 15,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kopczynski Casey C. (Chief Scientific Officer of Aerie Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.